Japan's Nikkei tracks Wall Street higher as Treasury yields fall

TOKYO, Sept 29 (Reuters) - Japan's Nikkei share average rose on Thursday, rebounding from a near three-month low touched in the previous session, tracking Wall Street's sharp gains overnight that was driven by falling Treasury yields.

The Nikkei .N225 gained 0.25% to 26,238.32, by the midday break, after rising about 1% earlier, recovering from a July 1 low of 25,936.36 hit on Wednesday. The broader Topix .TOPX inched down 0.08% to 1,853.63. "The main driver for the Nikkei's gain was an advance of Wall Street overnight, which was fuelled by the Bank of England's action," said Chihiro Ohta, assistant general manager at the investment research and investor services at SMBC Nikko Securities

Wall Street ended sharply higher overnight following its recent sell-off, after Treasuries yields fell, as the Bank of England stepped into the bond market in an attempt to dampen investor fears of contagion across the financial system.

In Japan, Uniqlo clothing shop owner Fast Retailing 9983.T rose 1.63%, becoming the biggest boost to the Nikkei, followed by technology investor SoftBank Group 9984.T , rising 1.17%.

Drug makers .IPHAM.T were the top gainer among the Tokyo Stock Exchange's industry sub-indexes, rising 2.53%.

Eisai shares 4523.T were set to hit their daily limit for a two straight sessions, after the surprise trial success of an experimental Alzheimer's drug developed by the Japanese drug maker and a partner Biogen BIIB.O .

Shionogi & Co 4507.T jumped 4.97%, while Chugai Pharmaceutical 4519.T gained 3.3% and Daiichi Sankyo 4568.T rose 2.23%.

Online shipping platform Rakuten Group 4755.T climbing 5.76% and was the top gainer on the Nikkei, followed by motorcycle maker Yamaha Corp 7951.T , rising 5.22.
Reporting y Junko Fujita; Editing by Rashmi Aich

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。


本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。